Your institution may have access to this item. Find your institution then sign in to continue.
Title
News in brief.
Abstract
Offers news briefs in the chemical industry as of March 2006. Approval of the bid of BASF for U.S. specialty chemicals and catalyst firm Engelhard by the European Commission; Decision of the U.S. Food and Drug Administration to not approve the drug Acomplia manufactured by Sanofi-Aventis; Creation of a new $200 million fund to invest in companies developing pandemic and biodefense-related technologies by Kleiner Perkins Caufield & Byers.